Biotech · Private company
Nocion Therapeutics
Track this companyFree. Adds Nocion Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- NOC-110Phase 2 · Refractory or Unexplained Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- 1 mg NOC-110 (via DPI) [1x 1 mg capsule]Phase 1 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- 3 mg NOC-100 (via nebulizer)Phase 1 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- 3 mg NOC-110 (via DPI)Phase 1 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- 6 mg NOC-110 (via DPI)Phase 1 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic CoughPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 24, 2024ClinicalTrials.gov NCT06504446 · fetched Nov 12, 2026
- Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175PHASE1 · COMPLETED · started Feb 7, 2022ClinicalTrials.gov NCT05628740 · fetched Nov 12, 2026